BAX
US EQUITY
Health Care
Health Care Equipment
CIK: 10456
Baxter International (BAX) Quant Factor Diagnostic & Fair Value Model
Baxter International (Ticker: BAX) is listed in the Health Care sector (Health Care Equipment). Below is its point-in-time financial profile, valuation multiples, and cross-sectional factor diagnostics.
$25.30
-1.36%
Latest Close (2026-10-23)
Market Cap: $13.08B
P/E Ratio: 26.4
Momentum Strength
3M / 12M
+8.40%
1M: +7.75%
12M: +10.34%
Quality (ROE)
Point-in-Time
+8.16%
Trailing Return on Equity
Technical Trend
RSI 14
60.0
SMA50: $24.77
SMA200: $21.23
Valuation Multiplier
Trailing
26.4
Moderate Valuation Corridor (15x - 30x P/E)
📊
Valuation & Multi-Factor Diagnostic
Moderate Valuation Corridor (15x - 30x P/E)
BAX trades within a typical sector multiple band (26.4x P/E), broadly aligned with trailing earnings.
⚡
Benchmark Factor Strategy
S&P 500 Momentum Alpha Strategy
This strategy applies cross-sectional momentum and quality factor filters across large-cap US equities.
📈 Daily Candlestick & Volume Quant Chart
Interactive lightweight price action & volume breakdown over recent 90 trading days.
均线多头 (MA20/50)
Piotroski F-Score: 8/9 (High Financial Strength)
Official Point-in-Time Financial Filing History
Zero Lookahead Bias: Every financial metric is timestamped at the exact moment officially published to the market.
备案 CIK: 10456 · 10-K 年报 / 10-Q 季报
| Form | Period End | Filing Timestamp (Point-in-Time) | Revenue | Net Income | Operating CF | EPS (Diluted) |
|---|---|---|---|---|---|---|
| 10-Q | 2026-06-30 | 2026-07-30 | $2.96B | $126.00M | $498.00M | $0.24 |
| 10-Q | 2025-12-31 | 2026-07-30 | - | - | - | - |
| 10-Q | 2025-06-30 | 2026-07-30 | $2.81B | $91.00M | $24.00M | $0.18 |
| 10-Q | 2026-03-31 | 2026-04-30 | $2.70B | -$15.00M | $213.00M | $-0.03 |
| 10-Q | 2025-03-31 | 2026-04-30 | $2.62B | $126.00M | -$193.00M | $0.25 |
| 10-K | 2025-12-31 | 2026-02-12 | $11.24B | -$957.00M | $845.00M | $-1.87 |
| 10-K | 2024-12-31 | 2026-02-12 | $2.75B | -$512.00M | $1.02B | $-1.00 |
| 10-K | 2023-12-31 | 2026-02-12 | $2.73B | $245.00M | $1.73B | $0.48 |
💡 Methodology & Frequently Asked Questions
Key reference details regarding Baxter International (BAX) valuation multiples, momentum factors, and point-in-time filing conventions.
How should BAX's current valuation multiple be interpreted? ↓
BAX trades at a trailing P/E of 26.4x within the Health Care sector (moderate valuation corridor (15x - 30x p/e)). Valuation multiples are computed using trailing-twelve-month GAAP earnings against the latest close price.
What are BAX's key momentum and technical factor indicators? ↓
As of the latest close, BAX shows a 1-month return of +7.75%, 3-month return of +8.40%, and 12-month return of +10.34%, with a 14-day RSI of 60.0. Momentum factors reflect short- and intermediate-term price velocity across the equity cross-section.
What is Point-in-Time (PIT) financial data and why does it matter for BAX? ↓
Point-in-Time indexing aligns corporate fundamentals with their official public filing timestamps (Form 10-Q/10-K) rather than accounting period-end dates. This methodology eliminates lookahead bias in historical equity backtests.
How can BAX be incorporated into systematic factor models? ↓
BAX can be evaluated within customized multi-factor models or screened against cross-sectional filters (such as momentum quintiles and return on equity) to analyze historical turnover and risk-adjusted return.